Aseel Yousef Altahrawi

Dr. Aseel Yousef Altahrawi

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2025 in Cells
Verified
Journal Article
Open access
PDF file
AAAseel Yousef Altahrawi
Aseel Yousef Altahrawi
William James AntonisamyWilliam James Antonisamy
William James Antonisamy
Zahoor A. ShahZahoor A. Shah
Zahoor A. Shah
Vascular dementia (VaD) is a heterogeneous group of brain disorders caused by cerebrovascular pathologies and the second most common cause of dementia, accounting for over 20% of cases and posing an important global health concern. VaD can be caused by cerebral infarction or injury in critical brain regions, including the speech area of the dominant hemisphere or arcuate fasciculus of the dominant hemisphere, leading to notable cognitive impairment. Although the exact causes of dementia remain multifactorial and complex, oxidative stress (reactive oxygen species), neuroinflammation (TNFα, IL-6, and IL-1β), and inflammasomes are considered central mechanisms in its pathology. These conditions contribute to neuronal damage, synaptic dysfunction, and cognitive decline. Thus, antioxidants and anti-inflammatory agents have emerged as potential therapeutic targets in dementia. Recent studies emphasize that cerebrovascular disease plays a dual role: first, as a primary cause of cognitive impairment and then as a contributor to the manifestation of dementia driven by other factors, such as Alzheimer’s disease and other neurodegenerative conditions. This comprehensive review of VaD focuses on molecular mechanisms and their consequences. We provided up-to-date knowledge about epidemiology, pathophysiological mechanisms, and current therapeutic approaches for VaD.

19 November 2025 in Molecular Neurobiology
Verified
Journal Article
Open access
PDF file
AAAseel Yousef Altahrawi
Aseel Yousef Altahrawi
William James AntonisamyWilliam James Antonisamy
William James Antonisamy
Zahoor A. ShahZahoor A. Shah
Zahoor A. Shah
Neuroinflammation and neuronal death are direct consequences of persistent microglial activation, a phenomenon observed in many chronic neurological conditions. Activated microglia impact neuronal cells by releasing proinflammatory cytokines and inflammatory mediators, leading to neuronal damage and neurodegeneration. To investigate whether polyinosinic polycytidylic acid (poly I:C), a synthetic double-stranded RNA molecule, induces neuroinflammation and neuronal death, we exposed human microglia (HMC-3 cells) to poly I:C for 24 h, and performed inflammatory cytokine analysis. Additionally, to investigate whether poly (I:C) induces memory impairment and motor coordination deficits in mice, we conducted a behavioral assessment and also measured the expression of inflammatory cytokines in the brain. Poly (I:C) exposure significantly increased the mRNA and protein expression of inflammasome, proinflammatory cytokines (TNFα, IL-6, IL-1β, IL-8, IL-12, and IL-18) and chemokines in microglia. Poly (I:C) also significantly increased the translocation of NF-kB from the cytosol to the nucleus. Furthermore, the conditioned medium from poly (I:C)-treated cells markedly increased apoptosis in human neuronal cells (differentiated SHSY5Y cells) by activating pro-apoptotic markers, including Bax, Bad, cleaved caspase-3, cleaved PARP, and AIF. Mice exposed to poly (I:C) showed a significant increase in mRNA expression of inflammatory cytokines, such as IL-6 and TNF-α, in the hippocampus. A decrease in the percentage of alternation on the T-maze, reduced distance travelled, and average speed in the open field test indicate cognitive deficits as well as anxiety-like behavior in mice exposed to poly (I:C). These findings suggest that poly (I:C) induces neuroinflammation through the inflammasome and proinflammatory mediators via the NLRP3/NF-κB signaling pathway in vitro and in vivo.

26 August 2025 in Research Square
Verified
Preprint
Open access
PDF file
AAAseel Yousef Altahrawi
Aseel Yousef Altahrawi
William James AntonisamyWilliam James Antonisamy
William James Antonisamy
Zahoor A. ShahZahoor A. Shah
Zahoor A. Shah
Neuroinflammation and neuronal death are direct consequences of persistent microglial activation observed in many chronic neurological conditions. Activated microglia impact neuronal cells by releasing proinflammatory cytokines and inflammatory mediators, leading to neuronal damage and neurodegeneration. To investigate whether Polyinosinic polycytidylic acid (poly I:C), a synthetic double-stranded RNA molecule, induces neuroinflammation and neuronal death, we exposed microglia (HMC-3 cells) to poly I: C for 24 hrs, and assessed inflammatory cytokines. Additionally, to investigate whether poly(I:C) induces memory impairment and motor coordination deficits in C57BL/6 mice, we conducted a behavioural assessment and measured the expression of inflammatory cytokines in the brain. Poly (I:C) exposure significantly increased the mRNA and protein expression of inflammasome, proinflammatory cytokines (TNFα, IL-6, IL-1β, IL-8, IL-12, and IL-18) and chemokines in microglia. Poly (I: C) also significantly increased the translocation of NF-kB from the cytosol to the nucleus. Furthermore, the conditioned medium from poly(I:C)-treated cells markedly increased apoptosis in human neuronal cells (differentiated SHSY5Y cells) by activating pro-apoptotic markers, including Bax, Bad, cleaved caspase-3, cleaved PARP, and AIF. In mice, exposure to poly (I:C) significantly increased the mRNA expression of inflammatory cytokines, such as IL-6 and TNF-α, in the hippocampus. It also decreased the percentage of alternation in the T-maze test and reduced the distance travelled and average speed in the open field test, indicating motor and cognitive deficits. These findings suggest that poly (I:C) induces neuroinflammation through the inflammasome and proinflammatory mediators via the NLRP3/NF-κB signaling pathway in vitro and in vivo and induces motor and memory impairment in mice.

12 October 2026 in Cells
Verified
Journal Article
Open access
PDF file
AAAseel Yousef Altahrawi
Aseel Yousef Altahrawi
FSFatimah Sofi
Fatimah Sofi
ZKZara Kanjwal
Zara Kanjwal
Zahoor A. ShahZahoor A. Shah
Zahoor A. Shah
Trimethylamine-N-oxide (TMAO) is a gut microbiota-derived metabolite produced through the hepatic oxidation of trimethylamine. Although TMAO has been widely investigated as a therapeutic target in multiple cardiovascular and metabolic diseases, growing evidence suggests it may play a critical role in the neuroinflammation and cognitive dysfunction associated with the gut–brain axis. This narrative review summarizes the current literature to synthesize evidence on the mechanisms linking TMAO with neurological disorders; it discusses potential mechanisms contributing to this association, with particular focus on neuroinflammation, oxidative stress, and activation of inflammatory pathways. Overall, this review also suggests the potential use of TMAO and its precursors as therapeutic targets for multiple neurodegenerative disorders. However, it emphasizes the need for conducting large, adequately powered randomized clinical studies to determine its therapeutic relevance.